The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.
NAFLD
breast cancer
cirrhosis
colorectal cancer
diffuse liver disease
hepatic viral infection
liver metastasis
lung cancer
pancreatic cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 May 2021
07 May 2021
Historique:
received:
07
04
2021
revised:
29
04
2021
accepted:
03
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
This systematic review with meta-analysis aimed to assess the effect of diffuse liver diseases (DLD) on the risk of synchronous (S-) or metachronous (M-) liver metastases (LMs) in patients with solid neoplasms. Relevant databases were searched for systematic reviews and cross-sectional or cohort studies published since 1990 comparing the risk of LMs in patients with and without DLD (steatosis, viral hepatitis, cirrhosis, fibrosis) in non-liver solid cancer patients. Outcomes were prevalence of S-LMs, cumulative risk of M-LMs and LM-free survival. Risk of bias (ROB) was assessed using the Newcastle-Ottawa Scale. We report the pooled relative risks (RR) for S-LMs and hazard ratios (HR) for M-LMs. Subgroup analyses included DLD, primary site and continent. Nineteen studies were included (
Identifiants
pubmed: 34067076
pii: cancers13092246
doi: 10.3390/cancers13092246
pmc: PMC8124499
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Surg Res. 1998 Mar;75(2):148-52
pubmed: 9655087
Ann Oncol. 2017 Feb 1;28(2):400-407
pubmed: 27831506
Ann Nutr Metab. 2016;68(3):173-9
pubmed: 26895247
J Natl Cancer Inst. 1988 Mar 16;80(2):102-8
pubmed: 2830405
Gastroenterol Clin North Am. 2020 Jun;49(2):179-189
pubmed: 32389357
Clin Infect Dis. 2018 Jun 1;66(12):1948-1952
pubmed: 29293940
Br J Cancer. 2016 Jun 28;115(1):34-9
pubmed: 27280634
Int J Mol Sci. 2020 Aug 16;21(16):
pubmed: 32824337
Hepatogastroenterology. 2012 Jul-Aug;59(117):1390-2
pubmed: 22172376
Minerva Chir. 2005 Jun;60(3):185-90
pubmed: 15985994
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Physiol Rev. 2003 Apr;83(2):337-76
pubmed: 12663862
HPB (Oxford). 2016 Apr;18(4):389-96
pubmed: 27037210
PeerJ. 2019 Mar 14;7:e6612
pubmed: 30886784
Int J Colorectal Dis. 2013 Aug;28(8):1065-72
pubmed: 23392476
N Engl J Med. 1991 Nov 7;325(19):1325-9
pubmed: 1656258
Ann Surg Oncol. 2014 Feb;21(2):501-6
pubmed: 24081807
Int J Cancer. 2011 Jun 1;128(11):2527-35
pubmed: 21365651
Minerva Chir. 2005 Apr;60(2):77-81
pubmed: 15973212
Trials. 2007 Jun 07;8:16
pubmed: 17555582
Hepatogastroenterology. 2000 Nov-Dec;47(36):1541-5
pubmed: 11148998
Clin Cancer Res. 2017 Nov 1;23(21):6390-6399
pubmed: 28615370
Clin Cancer Res. 2016 Dec 15;22(24):5971-5982
pubmed: 27797969
Jpn J Clin Oncol. 2015 Feb;45(2):160-8
pubmed: 25378650
J Hepatol. 2017 Jul;67(1):84-91
pubmed: 28284915
Int J Exp Pathol. 2020 Oct;101(5):162-170
pubmed: 32783302
Br J Surg. 2013 May;100(6):820-6
pubmed: 23354994
Science. 1989 Apr 21;244(4902):362-4
pubmed: 2496467
PLoS One. 2014 Sep 29;9(9):e108618
pubmed: 25265536
Hepatogastroenterology. 2014 Oct;61(135):1908-14
pubmed: 25713887
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Ann Ital Chir. 2013 May-Jun;84(3):323-7
pubmed: 22722140
World J Surg. 2018 Aug;42(8):2642-2650
pubmed: 29352337
Am J Surg. 1992 Aug;164(2):176-7
pubmed: 1636899
Breast Cancer Res Treat. 2017 Nov;166(1):289-297
pubmed: 28741275
Hepatogastroenterology. 1997 Jul-Aug;44(16):1069-75
pubmed: 9261601
Hepatogastroenterology. 2013 Jan-Feb;60(121):37-41
pubmed: 22944343
Nat Rev Cancer. 2002 Aug;2(8):563-72
pubmed: 12154349
Curr Probl Surg. 2018 Sep;55(9):330-379
pubmed: 30526930
J Transl Med. 2013 Oct 08;11:249
pubmed: 24099678